Bedel Financial Consulting, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Bedel Financial Consulting, Inc.
- $645 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
183Shares Held
54.4MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$254 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$171 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$129 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$110 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$108 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.44B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...